SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago ...Middle East

87% of patients receiving AKANTIOR® in the Phase 3 Trial were medically cured within a median duration of 4 months compared to 55% with the treatment protocols used in real-world clinical practice today. With the AKANTIOR® protocol used in the Phase 3 Trial, 62% of patients achieved full...

Hence then, the article about sifi reports detailed positive results and new data from the completed phase 3 trial of akantior in patients with acanthamoeba keratitis presented at the american academy of ophthalmology annual meeting in chicago was published today ( Thursday 13/10/2022 - 10:09 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SIFI Reports Detailed Positive Results and New Data from the Completed Phase 3 Trial of AKANTIOR® in Patients with Acanthamoeba Keratitis presented at the American Academy of Ophthalmology Annual Meeting in Chicago )

Also on site :

• Drone hysteria, Kiev gunfights, and aviation threats: RT stories that shaped the week
• ‘Harry Potter’ TV Series Due To Hit HBO Christmas 2026: Everything We Know About The Cast, Who’s Creating It, What J.K. Rowling Says & More
• ‘Tender Loving Care’ Review: Mike Leigh’s Tale of Social Workers, Lonely Hearts and Dementia Should Have Been a Fuller Portrait